91.50CHF+0.55%Mkt Cap: 144.13B $P/E: 28.772d ago
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nu…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap144.13B $
Enterprise Value211.41B $
Revenue (TTM)53.17B $
Gross Profit28.54B $
Net Income (TTM)7.45B $
Revenue/Share30.54 USD
Last Price91.50 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees122.0K
CountryCH
SectorHealthcare
IndustryMedical Devices
ISINUS0028241000
Valuation
P/E (Trailing)28.77
P/E (Forward)—
PEG2.23
EV/EBITDA15.86
EV/Revenue3.98
P/S2.69
P/B3.00
EPS (TTM)2.51
EPS (Forward)—
52W Range
89.50100% of range91.50
52W High91.50 CHF
52W Low89.50 CHF
Profitability
Gross Margin56.42%
Oper. Margin14.71%
EBITDA Margin25.07%
Profit Margin14.72%
ROE12.51%
ROA7.52%
Growth
Revenue Growth13.00%
Earnings Growth-47.50%
Cash Flow & Leverage
Operating CF10.92B $
CapEx (TTM)2.48B $
FCF Margin15.48%
FCF Yield5.71%
Net Debt30.95B $
Net Debt/EBITDA2.32
Balance Sheet
Debt/Equity0.27
Current Ratio1.38
Quick Ratio0.80
Book Value/Sh24.19 CHF
Cash/Share3.238 CHF
Dividends
Fwd Div Rate2.040 CHF
Trail. Div Rate2.480 CHF
Div. Yield2.25%
5Y Avg Yield1.93%
Payout Ratio78.96%
Ex-Div DateJul 15, 2026
Pay DateMay 15, 2025
Splits
Last Split2:1
Split DateJan 3, 2013
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.73B
Float1.72B
Insiders0.50%
Institutions82.06%
Technical
SMA 5079.49 (+15.1%)
SMA 20085.66 (+6.8%)
Beta0.58
S&P 52W Chg20.80%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—